Funding for this research was provided by:
GlaxoSmithKline (EPI-Rota-048; 201424)
Received: 26 September 2017
Accepted: 8 December 2017
First Online: 29 January 2018
Ethics approval and consent to participate
: Ethical approval was provided by NHS Research Ethics Committee, South Central-Berkshire (reference 14/SC/1140). Signed data-sharing agreements were obtained between NHS organisations and the University of Liverpool.
: Not applicable
: All authors have completed the ICMJE uniform disclosure form atExternalRef removedand declare: NC, NF, MIG, RV and DH are in receipt of research grant support from GlaxoSmithKline (GSK) Biologicals. Outside of this study, MIG and DH are in receipt of research grant support from Sanofi Pasteur-MSD (SPMSD) and NC has received honoraria for participation in GSK Rotavirus Vaccine Advisory Board Meetings.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.